These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1904850)

  • 1. The successful treatment of Branhamella catarrhalis bronchopulmonary infections in adults with amoxycillin.
    Seto WH; Yuen KY
    J Antimicrob Chemother; 1991 Jan; 27(1):146-7. PubMed ID: 1904850
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumonia due to Moraxella (Branhamella) catarrhalis.
    Wright PW; Wallace RJ
    Semin Respir Infect; 1989 Mar; 4(1):40-6. PubMed ID: 2496450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branhamella catarrhalis respiratory infections.
    Barreiro B; Esteban L; Prats E; Verdaguer E; Dorca J; Manresa F
    Eur Respir J; 1992 Jun; 5(6):675-9. PubMed ID: 1628725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of culture medium on the comparative in-vitro activity of amoxycillin and amoxycillin/clavulanic acid against Branhamella catarrhalis.
    Soriano F; Jiménez-Arriero M; Fernández-Roblas R
    J Antimicrob Chemother; 1987 Aug; 20(2):285-6. PubMed ID: 3117763
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimal criteria for identification of Moraxella (Branhamella) catarrhalis.
    Jönsson I; Eriksson B; Krook A
    APMIS; 1990 Oct; 98(10):954-6. PubMed ID: 2123112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance, isolation, identification and sensitivity of Branhaemella (moraxella) catarrhalis.
    Hafiz S; Hafiz T; Yazdani I
    J Pak Med Assoc; 1993 Aug; 43(8):153-4. PubMed ID: 8264093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of Moraxella catarrhalis in patients with respiratory tract infections].
    Jakubicz P; Leszczyńska K
    Med Dosw Mikrobiol; 1997; 49(1-2):55-60. PubMed ID: 9411073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G; Gaudio F; Ducroix JP; Orfila J
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N; Cheong YM; Tahir HM
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].
    Radzuweit S; Kalich R
    Z Erkr Atmungsorgane; 1991; 177(1-2):82-7. PubMed ID: 1808857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteremic pneumonia caused by Branhamella catarrhalis in an immunocompromised patient].
    Mendarte U; Collazos J; Egurbide MV; de Miguel J
    Med Clin (Barc); 1991 Apr; 96(14):559. PubMed ID: 1904967
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis.
    Jordan KL; Berk SH; Berk SL
    Am J Med; 1990 May; 88(5A):28S-32S. PubMed ID: 2111090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation of chronic bronchitis: what is the clinical significance of pathogenic bacteria in sputum cultures?
    Watanakunakorn C
    Chest; 2000 Dec; 118(6):1523-5. PubMed ID: 11115428
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G; Legnani D; De Bartolo A; Pagani N; Lusco G
    J Chemother; 1995 Nov; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchopulmonary infection due to Branhamella catarrhalis in patients with obstructive lung disease].
    Wu LB
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):328-30, 378. PubMed ID: 2128216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.